As of 2026-04-04, the Relative Valuation of Vaccibody AS (VACC.OL) is 7.17 NOK. This relative valuation is based on P/E multiples. With the latest stock price at 45.80 NOK, the upside of Vaccibody AS based on Relative Valuation is -84.3%.
The range of the Relative Valuation is 2.70 - 10.65 NOK.
| Range | Selected | |
| Trailing P/E multiples | 18.2x - 21.8x | 20.0x |
| Forward P/E multiples | 14.4x - 34.4x | 24.4x |
| Fair Price | 2.70 - 10.65 | 7.17 |
| Upside | -94.1% - -76.7% | -84.3% |
| Date | P/E |